Resumo

DIAZ-GRAVALOS, Gabriel J. et al. Suitability of inhaled therapy in patients diagnosed with chronic obstructive pulmonary disease (COPD). Rev Clin Med Fam [online]. 2013, vol.6, n.1, pp.4-9. ISSN 2386-8201.  https://dx.doi.org/10.4321/S1699-695X2013000100002.

Objective: To assess the compliance of inhaled therapy in patients diagnosed with chronic obstructive lung disease to clinical guidelines (GOLD). Design: Indication/prescription cross-sectional observational study. Location: Primary care in the province of Orense. Participants: All cases of COPD included in the register for 28 chronic patients in 9 health centres in the province of Orense. Main Surveyed Data. The following were determined: age, sex, spirometric data, adjustment of diagnosis based on  spirometric results, and inhaled drug therapy (long-acting anticholinergics, inhaled corticosteroids, long-acting beta-2 and short-acting beta-2). Results: 297 cases (77.7%) were male, with an average age of 77.0 years. The FEV1/ FVC ratio was registered in 174 (45.5%) patients. It was lower than 0.7 in 138 cases (36.1%) and FEV1 appeared in 125 cases (90.6%). 71 patients (56.8%) were classified as severe or very severe. The treatment was in accordance with recommendations in 26,4% of the cases. In 19.2% it was incorrect by default and in 54.4%, through over-medication, related primarily to the use of inhaled corticosteroids, which were correctly indicated in 9% of cases. There were no differences in the use of associated drugs based on the severity of the COPD. Conclusions: In COPD therapy with inhaled drugs, there is a low level of compliance with criteria recommended in the main clinical practice guidelines, especially regarding the use of corticosteroids.

Palavras-chave : Chronic obstructive pulmonary disease/therapy; Bronchodilators; glucocorticoids; Adhesion to guidelines; Quality of healthcare; Primary healthcare.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )